AI Summary

Researchers at the University of Birmingham, led by Professor Nicholas Barnes, have identified a key receptor whose blockage can suppress neuroinflammation in brain cells. Their findings, published in the journal Brain, suggest that an existing drug could be repurposed to target inflammatory conditions such as traumatic brain injury and Alzheimer’s disease. The study highlights the receptor as a potential therapeutic target for curbing brain inflammation.

AI summaries can be wrong sometimes—always verify important details using the source article.